Hepatitis
- Direct-Acting Antiviral Therapy Improves Survival in Chronic Hepatitis C
- Direct-Acting Antivirals Less Likely for Patients with Hepatitis C, Alcohol Use Disorder
- Hepatitis C Guideline Updated for Chronic Kidney Disease Population
- Bepirovirsen Therapy Shows Enhanced Efficacy for Chronic Hepatitis B Infection
- Lonafarnib-Based Regimens Look Promising for Patients With Chronic HDV Infection
- Bepirovirsen Studied for Treatment of Chronic Hepatitis B Infection
- Vemlidy Approved for Pediatric Patients With Chronic HBV Infection
- The Global Prevalence of Occult Hepatitis B Virus Is Significant
- Adjunctive Metformin Fails to Accelerate Hepatitis B Surface Antigen Clearance
- Hepatitis B Relapse Rates Differ After Treatment Discontinuation
- Kidney Allograft Survival Not Worse Despite Deceased-Donor HCV Infection
- Global Hepatitis B Rates Decline, But Mortality Rates Fall Short of WHO Target
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
